HighPoint Blog

In our first Life Science R&D blog, Paul Nelson talked about the major data challenges facing our industry today. Ultimately, those challenges boil down to what our team refers to as the volume, velocity, and variety of data.

Read More

Tender management is becoming increasingly important these days. Twenty five percent (25%) of the pharmaceutical market is now considered to be traded through some form of tender, and this percentage is expected to grow even further. The prevalence of tendering is nowadays expanding from generic to specialized drugs, forcing even specialized manufacturers to become participants in tender.

Read More

Managing the volume, variety and velocity of data is one of the best known—and least understood—challenges in the Life Sciences industry. According to IDC, data grows 50% year-over-year, which is significant. This tremendous growth is causing a major obstacle across the industry, specifically in the area of Research & Development.

Read More

Recent Posts

Tag